US Nuclear (OTC-QB: UCLE) has highlighted the pioneering work of Magneto Inertial Fusion Technology Inc (MIFTI) in fusion power development. Led by Dr. Hafiz Rahman, MIFTI recently showcased its nuclear fusion technology at the L3 Harris Lab in San Leandro, California. This demonstration resulted in an impressive yield of 150 billion neutrons, aligning precisely with advanced computer code predictions. A milestone unparalleled by any other private company globally.
Projections based on advanced simulations indicate that scaling up MIFTI’s nuclear fusion generator to 10 Mega Amps holds the promise of achieving net energy gain. This expansion also opens doors for the commercial production of essential medical isotopes crucial for hospital cancer scanning. US Nuclear, as a partner, investor, and potential prime contractor for MIFTI’s fusion power generator, eagerly anticipates further progress.
The field of fusion power development has seen a surge in breakthroughs owing to technological advancements and increased funding. Global investment in fusion has soared to a cumulative $6.21 billion. This is a substantial rise from $4.8 billion just a year earlier. Notably, Lawrence Livermore National Lab achieved positive net energy gain last year, a pivotal step toward fusion power commercialization. Moreover, Microsoft’s groundbreaking deal to procure commercial fusion energy from Helion Energy, starting in 2028, further underscores the industry’s momentum.
MIFTI stands out as the sole entity worldwide to have propelled staged Z-pinch fusion to a stage of significant energy emission through neutron production. Their unique approach confers numerous advantages, positioning them as frontrunners in the realm of fusion power generation.
MIFTI was established in 2008 by UC Irvine scientists with over 25 years dedicated to researching staged Z-pinch fusion technology. MIFTI’s extensive experimentation, comprehension, and advanced modeling substantiate the potential of their approach. Their method yields a net energy gain estimated to be between ten to fifty times the energy input. This holds promise to address global energy challenges. Furthermore, the adaptability of the staged Z-pinch approach extends to various applications. This includes the crucial production of medical scanning isotopes, offering a solution to the worldwide shortage valued at billions of dollars.